Global Pharma Healthcare, a biotech manufacturer based in India has recalled two of its eye-drop lubricant products due to possible bacterial contamination.
The products, sold under the names EzriCare Artificial Tears Lubricant Eye Drops and Delsam Pharma’s Artificial Tears Lubricant Eye Drops, have been linked to reports of eye infections, permanent loss of vision, and death by bloodstream infection.
On January 31, the CDC reported that 55 patients across 12 states had contracted Pseudomonas aeruginosa infections from open bottles of EzriCare Artificial Tears. Following the report, the FDA released a statement detailing their decision to place Global Pharma Healthcare on import alert for violating proper manufacturing practices.
“FDA recommended this recall due to the company’s current good manufacturing practice (CGMP) violations, including lack of appropriate microbial testing, formulation issues, and lack of proper controls concerning tamper-evident packaging.”
If you or a family member are using EzriCare or Delsam products, you should stop use immediately and contact a doctor if you experience the following symptoms of an eye infection:
- Blurred vision
- Discharge from the eye
- Dry eyes
- Eye pain or discomfort
- Redness on the eye or eyelid
- Sensitivity to light
Langdon & Emison is monitoring the situation closely. As skilled dangerous drugs lawyers with over 30 years of experience, we’ve successfully handled dozens of safety violations and defective product lawsuits.
If you or a loved one use EzriCare or Delsam eye drops and are experiencing any of the symptoms mentioned above, call our firm today at (866) 931-2115. You may be entitled to full compensation, and we can help you collect it.
The post Recalled eye drops linked to death, infection, and blindness appeared first on Langdon & Emison.
